Research across Pneumonia
Related studies from across the Pneumonia family.
Questions about Community-Acquired Pneumonia
What are the risks of co-infection in children with HMPV and severe community-acquired pneumonia?
Co-infection, especially with Mycoplasma pneumoniae, is a significant risk factor for severe CAP in children with HMPV, with studies showing higher rates of co-infection in severe cases.
Full answer →Are children with severe community-acquired pneumonia more likely to have Mycoplasma pneumoniae?
Yes, children with severe community-acquired pneumonia are more likely to have Mycoplasma pneumoniae, with studies showing higher detection rates in severe cases.
Full answer →Can machine learning predict mortality better than APACHE-II for severe community-acquired pneumonia?
Yes, machine learning models, particularly GBDT and XGBoost, have outperformed APACHE-II in predicting mortality for severe community-acquired pneumonia with respiratory failure.
Full answer →What is the severe community-acquired pneumonia rate for children with HMPV?
In a recent study of hospitalized children with HMPV, 28.0% had severe community-acquired pneumonia (CAP).
Full answer →How does the severity of community-acquired pneumonia affect the detection of Mycoplasma pneumoniae in children?
Severe community-acquired pneumonia in children is associated with higher detection rates of Mycoplasma pneumoniae compared to non-severe cases, likely due to higher bacterial load and immune response.
Full answer →Does amoxicillin work just as well as other antibiotics for community-acquired pneumonia?
Current evidence suggests amoxicillin is generally as effective as other antibiotics for community-acquired pneumonia, but the choice depends on local resistance patterns and patient factors.
Full answer →All Community-Acquired Pneumonia Articles
- Systemic corticosteroid therapy significantly decreased length of hospital stay and fever duration in children with community-acquired pneumonia
- High mortality rates observed in community-acquired pneumonia patients within intensive care units across low- and middle-income regions
- FDA approves nuzyra for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in adults
- Meta-analysis finds no clear difference between amoxicillin and other antibiotics for community-acquired pneumonia
- Hospitalized children with HMPV infection had 28.0% severe CAP rates and higher risks of wheezing and co-infection
- Nemonoxacin shows similar efficacy to moxifloxacin in hospitalized CAP patients
- Macrolide-resistant Mycoplasma pneumoniae prevalence at 94% in pediatric CAP cohort
- Machine learning models outperformed APACHE-II for predicting mortality in severe community-acquired pneumonia patients with respiratory failure
- tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP
- Systemic Immune-Inflammation Index predicts severe community-acquired pneumonia in pediatric patients
- Pyroptosis endotypes and malnutrition linked to mortality in older adults with community-acquired pneumonia
- Immune dysregulation score predicts mortality and identifies hydrocortisone responders in community-acquired pneumonia
- U.S. pediatric hospitals report increase in Mycoplasma pneumoniae pneumonia discharges in children
- Contezolid shows 80% clinical cure rate in small pneumonia study with good pulmonary penetration